Methotrexate metabolism

G R Krakower et al. Cancer Chemother Pharmacol. 1983.

. 1983;10(3):230-1.

doi: 10.1007/BF00255773.

No abstract available

Similar articles

Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment.
Schrøder H, Clausen N, Ostergaard E, Pressler T. Schrøder H, et al. Cancer Chemother Pharmacol. 1986;16(2):190-3. doi: 10.1007/BF00256175. Cancer Chemother Pharmacol. 1986. PMID: 3456283
Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis.
Furst DE. Furst DE. J Rheumatol Suppl. 1985 Dec;12 Suppl 12:11-4. J Rheumatol Suppl. 1985. PMID: 3913770 Review.
The effect of encapsulation in red blood cells on the distribution of methotrexate in mice.
Zimmermann U, Pilwat G, Esser B. Zimmermann U, et al. J Clin Chem Clin Biochem. 1978 Feb;16(2):135-44. doi: 10.1515/cclm.1978.16.2.135. J Clin Chem Clin Biochem. 1978. PMID: 624912 No abstract available.
Clinical pharmacokinetics of methotrexate.
Shen DD, Azarnoff DL. Shen DD, et al. Clin Pharmacokinet. 1978 Jan-Feb;3(1):1-13. doi: 10.2165/00003088-197803010-00001. Clin Pharmacokinet. 1978. PMID: 346283 Review. No abstract available.
Pharmacokinetic interactions of cyclophosphamide and 5-fluorouracil with methotrexate in an animal model.
de Bruijn EA, Driessen O, Leeflang P, van den Bosch N, van Strijen E, Slee PH, Hermans J. de Bruijn EA, et al. Cancer Treat Rep. 1986 Oct;70(10):1159-65. Cancer Treat Rep. 1986. PMID: 3756938

Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.
Schrøder H, Fogh K. Schrøder H, et al. Cancer Chemother Pharmacol. 1988;21(2):145-9. doi: 10.1007/BF00257362. Cancer Chemother Pharmacol. 1988. PMID: 2450690
Methotrexate pharmacokinetics in age-fractionated erythrocytes.
Schrøder H. Schrøder H. Cancer Chemother Pharmacol. 1986;18(3):203-7. doi: 10.1007/BF00273386. Cancer Chemother Pharmacol. 1986. PMID: 3467879